Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
349 studies found for:    Amyotrophic Lateral Sclerosis (ALS)
Show Display Options
Rank Status Study
21 Completed
Has Results
Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis;   ALS
Interventions: Biological: HYNR-CS inj;   Other: Control group
22 Active, not recruiting Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Rasagiline;   Drug: Placebo
23 Completed Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo;   Drug: MCI-186 in open label phase
24 Unknown  Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Creatine Monohydrate
25 Recruiting The National Amyotrophic Lateral Sclerosis Registry
Condition: Amyotrophic Lateral Sclerosis
Intervention:
26 Completed A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: E0302 (mecobalamin);   Drug: Placebo
27 Suspended Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
28 Unknown  Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Olanzapine
29 Unknown  Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: Intramuscular diaphragm electrodes
30 Completed Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: KNS-760704;   Drug: Placebo
31 Completed Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea
Conditions: Sialorrhea;   Amyotrophic Lateral Sclerosis
Interventions: Drug: Botox injection;   Drug: Placebo injection
32 Enrolling by invitation Biological Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Biological: Cell-based therapeutics;   Other: Symptomatic treatment of ALS
33 Recruiting Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: Non-invasive home ventilation
34 Recruiting Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Other: ALS Functional rating Scale-revised (ALS FRS-R);   Other: slow vital capacity;   Other: Blood sample;   Other: Cerebrospinal Fluid (CSF) sample
35 Unknown  Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Anakinra
36 Completed Amyotrophic Lateral Sclerosis (ALS) Gulf War Study
Condition: Amyotrophic Lateral Sclerosis
Intervention:
37 Active, not recruiting Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients
Conditions: ALS (Amyotrophic Lateral Sclerosis);   Iron Overload
Intervention: Drug: Deferiprone
38 Unknown  Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples
Condition: Amyotrophic Lateral Sclerosis
Intervention:
39 Unknown  Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: MRI + 18FDG-PET + neuropsychological assessments ; 18FDG performed especially for the research
40 Unknown  A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: lithium carbonate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years